Layer Pharma - Company finances
|
EUR
|
2020
From: 2020-01-20
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | - | - | 21,389 | 176,977 | - | - |
| Profit before tax | - | - | - | - | - | - |
| Net profit | -6,029 | -31,031 | -14,920 | 78,515 | -15,332 | -16,263 |
| Equity | -3,277 | -34,308 | -16,228 | 62,287 | 8,655 | 146,340 |
| Liabilities | 4,231 | 35,941 | 5,124 | 3,770 | 1,709 | 33,226 |
| Non-current assets | 0 | 2,676 | 1,882 | 10,171 | 6,731 | 564,482 |
| Current assets | 958 | 29,959 | 17,603 | 60,024 | 6,383 | 23,253 |
| Total assets | 958 | 32,635 | 19,485 | 70,195 | 13,114 | 587,735 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 7,797 | - | 6,149 |
| Social insurance contributions | - | - | - | 19,375 | 510 | 4,716 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | - | +727.4% | - | - |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -629.3% | -95.1% | -76.6% | 111.9% | -116.9% | -2.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | 126.1% | -177.1% | -11.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | -69.8% | 44.4% | - | - |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.1 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 4,010 | 28,316 | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Layer Pharma - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-19 | 2026-08-19 | 35.51 |
| 2026-08-16 | 2026-08-17 | 0.34 |
| 2026-07-23 | 2026-08-14 | 0.34 |
| 2026-06-11 | 2026-06-14 | 8.24 |
| 2026-05-17 | 2026-06-08 | 8.24 |
| 2026-05-03 | 2026-05-14 | 8.24 |
| 2026-04-24 | 2026-04-29 | 8.24 |
| 2026-04-20 | 2026-04-23 | 143.35 |
| 2026-02-18 | 2026-03-01 | 916.11 |
| 2026-02-02 | 2026-02-17 | 458.55 |
| 2026-01-28 | 2026-02-01 | 702.93 |
| 2026-01-21 | 2026-01-27 | 729.11 |
| 2026-01-16 | 2026-01-20 | 723.34 |
| 2025-11-19 | 2025-11-30 | 552.42 |
| 2025-11-18 | 2025-11-18 | 945.50 |
| 2025-11-17 | 2025-11-17 | 393.53 |
| 2025-10-24 | 2025-11-16 | 393.08 |
| 2025-10-16 | 2025-10-23 | 469.71 |
| 2025-08-28 | 2025-08-29 | 517.93 |
| 2025-08-19 | 2025-08-19 | 517.93 |
| 2025-07-24 | 2025-08-18 | 0.03 |
| 2025-06-11 | 2025-06-11 | 0.03 |
| 2025-06-08 | 2025-06-09 | 0.03 |
| 2025-05-16 | 2025-06-04 | 0.03 |
| 2025-05-04 | 2025-05-12 | 0.03 |
| 2025-04-24 | 2025-04-29 | 0.03 |
| 2025-02-18 | 2025-03-06 | 0.18 |
| 2025-01-22 | 2025-02-13 | 0.18 |
| 2024-10-24 | 2024-11-06 | 0.07 |
| 2024-10-16 | 2024-10-17 | 173.37 |
| 2024-08-19 | 2024-08-27 | 0.02 |
| 2024-07-24 | 2024-08-15 | 0.02 |
| 2024-07-16 | 2024-07-17 | 127.38 |
| 2024-04-16 | 2024-04-17 | 17.03 |
| 2023-01-17 | 2023-01-22 | 1321.48 |
| 2022-12-16 | 2022-12-19 | 1321.48 |
| 2022-09-16 | 2022-09-19 | 1693.14 |
| 2021-09-16 | 2021-09-20 | 1349.44 |
Layer Pharma - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-11 | 2025-05-13 | 1319.63 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.